Abstract
The Inhibitor of Apoptosis proteins (IAPs) are a family of proteins that are mainly known for their anti-apoptotic activity and ability to directly bind and inhibit caspases. Recent research has however revealed that they have extensive roles in governing numerous other cellular processes. IAPs are known to modulate ubiquitin (Ub)-dependent signaling pathways through their E3 ligase activity and influence activation of nuclear factor κB (NF-κB). In this review, we discuss the involvement of IAPs in individual hallmarks of cancer and the current status of therapies targeting these critical proteins.
Original language | English |
---|---|
Article number | 107610 |
Pages (from-to) | 107610 |
Number of pages | 19 |
Journal | Pharmacology and Therapeutics |
Volume | 214 |
Early online date | 23 Jun 2020 |
DOIs | |
Publication status | Published - Oct 2020 |
Bibliographical note
Copyright © 2020 Elsevier Inc. All rights reserved.ASJC Scopus subject areas
- Oncology
Fingerprint
Dive into the research topics of 'The Multiple Roles of the IAP Super-family in cancer'. Together they form a unique fingerprint.Student theses
-
Proteomics and metabolomics-based identification of novel treatment strategies in pancreatic ductal adenocarcinoma
Kumar, S. (Author), Turkington, R. (Supervisor) & Kerr, E. (Supervisor), Dec 2022Student thesis: Doctoral Thesis › Doctor of Philosophy